Literature DB >> 8591719

Dichloroacetic acid: metabolism in cytosol.

J C Lipscomb1, D A Mahle, W T Brashear, H A Barton.   

Abstract

Dichloroacetic acid (DCA) arises from the chlorination of drinking water and the metabolism of trichloroethylene (TRI) and is used therapeutically. The toxicity of TRI exposure is dependent on metabolism, and DCA has been proposed to be one contributor to this toxicity. Beyond the identification of some metabolites of DCA and some pharmacokinetic studies, little is known about the tissue distribution and enzymology of DCA metabolism. We present data that indicate that DCA degradation occurs primarily in the cytosol. Low molecular weight components of cytosol are required for the reaction, including nicotinamide cofactor and glutathione (GSH). GSH plays a role in the removal of DCA from cytosol, although not through transferase-mediated conjugation. In rat cytosol, the KM is approximately 0.3 mM, and the apparent Vmax approximates 12 nmoles/min/mg cytosolic protein. These results set DCA apart from other chlorinated compounds that are metabolized by the cytochrome P450 enzyme family.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8591719

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  13 in total

1.  Dichloroacetate- and Trichloroacetate-Induced Modulation of Superoxide Dismutase, Catalase, and Glutathione Peroxidase Activities and Glutathione Level in the livers of Mice after Subacute and Subchronic exposure.

Authors:  Ezdihar A Hassoun; Jacquelyn Cearfoss
Journal:  Toxicol Environ Chem       Date:  2011-02       Impact factor: 1.437

2.  Regulation of dichloroacetate biotransformation in rat liver and extrahepatic tissues by GSTZ1 expression and chloride concentration.

Authors:  Stephan C Jahn; Marci G Smeltz; Zhiwei Hu; Laura Rowland-Faux; Guo Zhong; Ryan J Lorenzo; Katherine V Cisneros; Peter W Stacpoole; Margaret O James
Journal:  Biochem Pharmacol       Date:  2018-04-05       Impact factor: 5.858

Review 3.  Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.

Authors:  Margaret O James; Stephan C Jahn; Guo Zhong; Marci G Smeltz; Zhiwei Hu; Peter W Stacpoole
Journal:  Pharmacol Ther       Date:  2016-10-19       Impact factor: 12.310

4.  The effect of dichloroacetate on male rat thymus and on thymocyte cell cycle.

Authors:  Jurate Stanevičiūtė; Daiva Urbonienė; Angelija Valančiūtė; Ingrida Balnytė; Astra Vitkauskienė; Brigita Grigalevičienė; Donatas Stakišaitis
Journal:  Int J Immunopathol Pharmacol       Date:  2016-10-14       Impact factor: 3.219

5.  Do Antioxidant Enzymes and Glutathione Play Roles in the Induction of Hepatic Oxidative Stress in Mice upon Subchronic Exposure to Mixtures of Dichloroacetate and Trichloroacetate?

Authors:  Ezdihar Hassoun; Jacquelyn Cearfoss
Journal:  Toxicol Environ Chem       Date:  2014-03       Impact factor: 1.437

6.  Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid.

Authors:  Z Tong; P G Board; M W Anders
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

Review 7.  Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity.

Authors:  Lawrence H Lash; Weihsueh A Chiu; Kathryn Z Guyton; Ivan Rusyn
Journal:  Mutat Res Rev Mutat Res       Date:  2014 Oct-Dec       Impact factor: 5.657

8.  Pharmacokinetic analysis of trichloroethylene metabolism in male B6C3F1 mice: Formation and disposition of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine.

Authors:  Sungkyoon Kim; David Kim; Gary M Pollack; Leonard B Collins; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2009-05-03       Impact factor: 4.219

9.  Physiologically based pharmacokinetic modeling of dibromoacetic acid in F344 rats.

Authors:  Jessica L Matthews; Irvin R Schultz; Michael R Easterling; Ronald L Melnick
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-04       Impact factor: 4.219

Review 10.  Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.

Authors:  H J Clewell; P R Gentry; T R Covington; J M Gearhart
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.